Titan Pharmaceuticals News

10-Q: Q1 2024 Earnings Report

May 15 16:26 ET

RW: Registration Withdrawal Request

Apr 26 09:43 ET

Titan Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Sire Group Ltd.(14.1%),Seow Gim Shen(14.1%)

Apr 5 16:39 ET

Titan Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Mokhtar Firdauz

Apr 5 10:18 ET

Titan Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Flores Francisco

Apr 5 10:18 ET

Titan Pharmaceuticals | 8-K: Current report

Apr 3 17:16 ET

Titan Pharmaceuticals | 10-K: FY2023 Annual Report

Apr 1 17:15 ET

Titan Pharmaceuticals | 8-K: Current report

Apr 1 17:11 ET

Titan Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Choong Choon Hau

Mar 27 09:49 ET

Titan Pharmaceuticals | 8-K: Current report

Mar 21 12:21 ET

Titan Pharmaceuticals | 8-K: Current report

Feb 8 11:51 ET

Titan Pharmaceuticals | 8-K: Current report

Jan 25 16:36 ET

Titan Pharmaceuticals | 8-K: Current report

Jan 18 00:00 ET

Titan Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET

Titan Pharmaceuticals | 8-K: Current report

Dec 28, 2023 00:00 ET

Titan Pharmaceuticals | DEF 14A: Definitive information statements

Nov 28, 2023 16:47 ET

Titan Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 17, 2023 16:03 ET

Titan Pharmaceuticals | 8-K: Current report

Nov 15, 2023 16:05 ET

Titan Pharmaceuticals: Q3 2023 Earnings Report

Nov 14, 2023 16:15 ET

Titan Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NATAN DAVID

Oct 26, 2023 16:33 ET